STOXPO
  • Latest News
  • Technology
    • Software
    • Semiconductors
  • Healthcare
    • Biotechnology
    • Pharmaceuticals
  • Crypto
    • Altcoins
    • Bitcoin
    • Ethereum
  • Companies
    • Micro-Cap
    • Small-Cap
    • Mid-Cap
    • Large-Cap
    • Mega-Cap
  • Q&A’s
  • Contributions
No Result
View All Result
  • Latest News
  • Technology
    • Software
    • Semiconductors
  • Healthcare
    • Biotechnology
    • Pharmaceuticals
  • Crypto
    • Altcoins
    • Bitcoin
    • Ethereum
  • Companies
    • Micro-Cap
    • Small-Cap
    • Mid-Cap
    • Large-Cap
    • Mega-Cap
  • Q&A’s
  • Contributions
No Result
View All Result
STOXPO
No Result
View All Result
Home Companies Large-Cap
vaccine-2

Vaccine Stocks Continue to Slide as Trump Names RFK Jr. to Lead HHS

byLuca Blaumann
November 15, 2024
in Large-Cap
Reading Time: 2 mins read
Share on TwitterShare on LinkedIn

Market Responds to Kennedy’s Anti-Vaccine Stance Amid Healthcare Policy Uncertainty

Shares of vaccine makers Moderna (MRNA), Novavax (NVAX), and Pfizer (PFE) extended their recent declines in premarket trading on Friday, following President-elect Donald Trump’s announcement that he intends to appoint Robert F. Kennedy Jr. as Secretary of Health and Human Services (HHS). The news sent ripples through the healthcare sector, with Moderna and Novavax stocks each down more than 30% over the past month as uncertainty grows regarding future vaccine policies.

The slide continued after Trump confirmed the nomination on X (formerly Twitter) following Thursday’s market close. His announcement included a statement that “the safety and health of all Americans” would be a priority, emphasizing HHS’s role in protecting the public from “harmful chemicals, pollutants, pesticides, pharmaceutical products, and food additives.” This message, along with Trump’s comments during a recent rally where he promised to let Kennedy “go wild” on healthcare reform, has fueled concerns in the market about a potential shift away from vaccine support.

Kennedy, who briefly entered the 2024 presidential race before endorsing Trump, is known for his vocal criticism of vaccines. His nonprofit organization, Children’s Health Defense, has often criticized vaccines, and he has personally expressed skepticism over vaccine safety and effectiveness. Despite Kennedy’s controversial stance, he attempted to allay fears in a recent NPR interview, stating, “we’re not going to take vaccines away from anybody.” However, this assurance has done little to mitigate market concerns, as Kennedy’s longstanding position against certain vaccinations remains well-documented.

The impact on vaccine stocks has been profound. Moderna and Novavax shares both fell over 1% in premarket trading Friday, with further after-hours declines. Investors appear wary of how Kennedy’s potential leadership at HHS might shape policies related to vaccine approval, funding, and distribution, as well as broader healthcare regulations.

For pharmaceutical companies heavily invested in vaccine research and development, Trump’s appointment of Kennedy introduces a new layer of uncertainty. As the transition unfolds, market participants will likely remain cautious, watching closely for any indications of how HHS may approach vaccine and pharmaceutical regulations under Kennedy’s direction.

You might like this:Disney’s Streaming Success and Strategic Vision Drive Strong Q4 Earnings

Tags: GrowthMoversNewsStock Market
Previous Post

Disney’s Streaming Success and Strategic Vision Drive Strong Q4 Earnings

Next Post

Electric Vehicle Industry Pleads with Trump to Preserve Tax Credits: Jobs and Investments at Stake

Related Posts

investing

Qualcomm Enters the AI Data Center Battle with Powerful New AI200 and AI250 Chips

byLiliana Vida
October 27, 2025
0

Chipmaker aims to challenge Nvidia and AMD with energy-efficient AI servers and next-generation accelerators launching in 2026 Qualcomm (NASDAQ: QCOM)...

trading-chart

AMD Shares Surge as IBM Taps Its Chips for Quantum Computing Breakthrough

byLuca Blaumann
October 24, 2025
0

Partnership fuels investor optimism as IBM prepares to launch its first quantum computer by 2029 Shares of Advanced Micro Devices...

trading-chart

Intel Surges After Strong Q3 Earnings Beat, But Manufacturing Challenges Remain

byLuca Blaumann
October 23, 2025
0

Chipmaker posts surprise profit and revenue growth amid AI-driven demand and government-backed investments Intel Corporation (INTC) saw its stock jump...

Next Post
ev-charging

Electric Vehicle Industry Pleads with Trump to Preserve Tax Credits: Jobs and Investments at Stake

Latest News

Purple Biotech Reaches Key Manufacturing Milestone for Groundbreaking Tri-Specific Antibody IM1240

Orion Group Holdings Delivers Strong Q3 Results and Raises 2025 Guidance

Nvidia Partners with U.S. Department of Energy to Build Seven AI Supercomputers

Qualcomm Enters the AI Data Center Battle with Powerful New AI200 and AI250 Chips

Co-Diagnostics Expands Global Reach with New Saudi Joint Venture

Based on Your Interest

investing
Artificial Intelligence

Datavault AI and Wellgistics Partner to Revolutionize Prescription Tracking with Blockchain Technology

October 24, 2025
trading-chart
Large-Cap

AMD Shares Surge as IBM Taps Its Chips for Quantum Computing Breakthrough

October 24, 2025
trading-chart
Large-Cap

Intel Surges After Strong Q3 Earnings Beat, But Manufacturing Challenges Remain

October 23, 2025

Recommended

Auto Manufacturers

Ford Beats Q3 Estimates but Cuts 2025 Outlook Following Supplier Fire

October 23, 2025
Biotechnology

Scienture Launches Commercial Sales of Arbli™, the First FDA-Approved Ready-to-Use Losartan Suspension

October 23, 2025
Auto Manufacturers

Earnings Season Heats Up as Tesla, Netflix, and Auto Giants Take Center Stage

October 23, 2025
Auto Manufacturers

Tesla’s Record Revenue Tops Forecasts

October 22, 2025
Foods

Beyond Meat’s (BYND) Rocky Road: Near-Term Opportunity or Caution Ahead?

October 22, 2025
Stoxpo

Follow us on social media:

Highlights

  • Purple Biotech Reaches Key Manufacturing Milestone for Groundbreaking Tri-Specific Antibody IM1240
  • Orion Group Holdings Delivers Strong Q3 Results and Raises 2025 Guidance
  • Nvidia Partners with U.S. Department of Energy to Build Seven AI Supercomputers
  • Qualcomm Enters the AI Data Center Battle with Powerful New AI200 and AI250 Chips
  • Co-Diagnostics Expands Global Reach with New Saudi Joint Venture

Category

  • Blog
  • Communication Services
    • Entertainment
    • Internet
    • Telecommunications
  • Companies
    • Large-Cap
    • Mega-Cap
    • Micro-Cap
    • Mid-Cap
    • Small-Cap
  • Consumer Cyclical
    • Auto Manufacturers
    • Casinos & Gambling
    • Ground Transportation
    • Hospitality
      • Casinp
      • Resorts & Lodging
      • Restaurants
      • Travel
        • Airlines
    • Retail
    • Textiles, Apparel & Luxury Goods
  • Consumer Defensive
    • Beverages
    • Discount Stores
    • Distributor
    • Ecommerece
    • Electrical Equipment
    • Foods
    • Household & Personal Products
    • Leisure Products
    • Tobacco
  • Contributions
  • Crypto
    • Altcoins
    • Bitcoin
    • Ethereum
  • Economy
  • Energy
    • Electric
    • Oil & Gas
    • Renewables
  • Financial Services
    • Asset Management
    • Banks
    • Brokerages
    • Credit Services
    • Insurance
  • Healthcare
    • Biotechnology
    • Medical Devices
    • Pharmaceuticals
  • Industrials
    • Aerospace & Defense
    • Construction
    • Industrial Machinery
  • Materials
    • Building Materials
    • Chemicals
    • Gold
    • Mining
    • Silver
    • Steel
  • Q&A's
  • Real Estate
  • Technology
    • Artificial Intelligence
    • Computer Hardware
    • Consumer Electronics
    • Cybersecurity
    • IT Services
    • Semiconductors
    • Software
  • Utilities

Latest News

scientist

Purple Biotech Reaches Key Manufacturing Milestone for Groundbreaking Tri-Specific Antibody IM1240

October 29, 2025

Orion Group Holdings Delivers Strong Q3 Results and Raises 2025 Guidance

October 28, 2025
nvidia-chip

Nvidia Partners with U.S. Department of Energy to Build Seven AI Supercomputers

October 28, 2025
  • About
  • Privacy Policy
  • Contact

© 2024 All Rights Reserved: STOXPO.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Read More

In case of sale of your personal information, you may opt out by using the link Do Not Sell My Personal Information

Accept Cookie Settings
Cookies are small text files that can be used by websites to make a user's experience more efficient. The law states that we can store cookies on your device if they are strictly necessary for the operation of this site. For all other types of cookies we need your permission. This site uses different types of cookies. Some cookies are placed by third party services that appear on our pages.
  • Always Active
    Necessary
    Necessary cookies help make a website usable by enabling basic functions like page navigation and access to secure areas of the website. The website cannot function properly without these cookies.
  • Marketing
    Marketing cookies are used to track visitors across websites. The intention is to display ads that are relevant and engaging for the individual user and thereby more valuable for publishers and third party advertisers.
  • Analytics
    Analytics cookies help website owners to understand how visitors interact with websites by collecting and reporting information anonymously.
  • Preferences
    Preference cookies enable a website to remember information that changes the way the website behaves or looks, like your preferred language or the region that you are in.
  • Unclassified
    Unclassified cookies are cookies that we are in the process of classifying, together with the providers of individual cookies.
Cookie Settings

Do you really wish to opt-out?

No Result
View All Result
  • Latest News
  • Healthcare
    • Biotechnology
    • Pharmaceuticals
  • Technology
    • Software
    • Semiconductors
  • Crypto
    • Bitcoin
    • Ethereum
    • Altcoins
  • Companies
    • Micro-Cap
    • Small-Cap
    • Mid-Cap
    • Large-Cap
    • Mega-Cap
  • Q&A’s
  • Contributions

© 2024 All Rights Reserved: STOXPO.